NO20005937L - Fremgangsmåte for separering og/eller isolering av plasmaproteiner ved annulær kromatografi - Google Patents

Fremgangsmåte for separering og/eller isolering av plasmaproteiner ved annulær kromatografi

Info

Publication number
NO20005937L
NO20005937L NO20005937A NO20005937A NO20005937L NO 20005937 L NO20005937 L NO 20005937L NO 20005937 A NO20005937 A NO 20005937A NO 20005937 A NO20005937 A NO 20005937A NO 20005937 L NO20005937 L NO 20005937L
Authority
NO
Norway
Prior art keywords
plasma proteins
separation medium
annular design
separating
isolating plasma
Prior art date
Application number
NO20005937A
Other languages
English (en)
Other versions
NO20005937D0 (no
Inventor
Andrea Buchacher
Djuro Josic
Gerhard Gruber
Adalbert Prior
Juergen Wolfgang
Original Assignee
Octapharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Octapharma Ag filed Critical Octapharma Ag
Publication of NO20005937D0 publication Critical patent/NO20005937D0/no
Publication of NO20005937L publication Critical patent/NO20005937L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424Serine endopeptidases (3.4.21)
    • C12N9/644Coagulation factor IXa (3.4.21.22)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745Blood coagulation or fibrinolysis factors
    • C07K14/755Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/76Albumins
    • C07K14/765Serum albumin, e.g. HSA
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81Protease inhibitors
    • C07K14/8107Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8121Serpins
    • C07K14/8125Alpha-1-antitrypsin
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/06Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065Purification, fragmentation
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424Serine endopeptidases (3.4.21)
    • C12N9/6429Thrombin (3.4.21.5)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424Serine endopeptidases (3.4.21)
    • C12N9/647Blood coagulation factors not provided for in a preceding group or according to more than one of the proceeding groups
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y304/00Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21Serine endopeptidases (3.4.21)
    • C12Y304/21005Thrombin (3.4.21.5)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y304/00Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21Serine endopeptidases (3.4.21)
    • C12Y304/21022Coagulation factor IXa (3.4.21.22)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Toxicology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Physical Or Chemical Processes And Apparatus (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Enzymes And Modification Thereof (AREA)
NO20005937A 1998-05-27 2000-11-24 Fremgangsmåte for separering og/eller isolering av plasmaproteiner ved annulær kromatografi NO20005937L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19823814A DE19823814A1 (de) 1998-05-27 1998-05-27 Verfahren zur Trennung und/oder Isolierung von Plasmaproteinen mit annularer Chromatographie
PCT/EP1999/003659 WO1999061475A1 (de) 1998-05-27 1999-05-27 Verfahren zur trennung und/oder isolierung von plasmaproteinen mit annularer chromatographie

Publications (2)

Publication Number Publication Date
NO20005937D0 NO20005937D0 (no) 2000-11-24
NO20005937L true NO20005937L (no) 2000-12-06

Family

ID=7869153

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20005937A NO20005937L (no) 1998-05-27 2000-11-24 Fremgangsmåte for separering og/eller isolering av plasmaproteiner ved annulær kromatografi

Country Status (18)

Country Link
US (1) US20020035241A1 (no)
EP (1) EP1080112B1 (no)
JP (1) JP2002516341A (no)
KR (1) KR20010043827A (no)
CN (1) CN1145642C (no)
AT (1) ATE246204T1 (no)
AU (1) AU756932B2 (no)
BR (1) BR9911591A (no)
CA (1) CA2333316A1 (no)
DE (2) DE19823814A1 (no)
DK (1) DK1080112T3 (no)
EA (1) EA003708B1 (no)
ES (1) ES2203150T3 (no)
IL (1) IL139120A0 (no)
NO (1) NO20005937L (no)
PT (1) PT1080112E (no)
WO (1) WO1999061475A1 (no)
ZA (1) ZA200109623B (no)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005121163A2 (en) * 2004-06-07 2005-12-22 Upfront Chromatography A/S Isolation of plasma or serum proteins
US7449116B2 (en) * 2004-10-01 2008-11-11 Agilent Technologies, Inc. Methods and systems for protein separation
GB0614315D0 (en) 2006-07-19 2006-08-30 Ge Healthcare Bio Sciences Ab Chromatography columns, systems and methods
CA2683977C (en) 2007-03-14 2017-04-25 Ligocyte Pharmaceuticals, Inc. A method of norovirus virus-like particle purification comprising ion exchange chromatography
AU2011343813B2 (en) 2010-12-15 2015-05-21 Takeda Pharmaceutical Company Limited Eluate collection using conductivity gradient
JOP20130186B1 (ar) 2012-06-22 2021-08-17 Takeda Vaccines Montana Inc تنقية الجزيئات الشبيهة بالفيروسات

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT405025B (de) * 1997-12-01 1999-04-26 Prior Eng Ag Annularchromatograph

Also Published As

Publication number Publication date
KR20010043827A (ko) 2001-05-25
CN1145642C (zh) 2004-04-14
CA2333316A1 (en) 1999-12-02
US20020035241A1 (en) 2002-03-21
DE19823814A1 (de) 1999-12-02
ATE246204T1 (de) 2003-08-15
WO1999061475A8 (de) 2000-02-03
BR9911591A (pt) 2001-02-13
WO1999061475A1 (de) 1999-12-02
AU4501499A (en) 1999-12-13
AU756932B2 (en) 2003-01-30
JP2002516341A (ja) 2002-06-04
EP1080112B1 (de) 2003-07-30
DK1080112T3 (da) 2003-11-24
EA003708B1 (ru) 2003-08-28
EA200001233A1 (ru) 2001-06-25
CN1303392A (zh) 2001-07-11
NO20005937D0 (no) 2000-11-24
PT1080112E (pt) 2003-12-31
EP1080112A1 (de) 2001-03-07
ZA200109623B (en) 2002-08-28
ES2203150T3 (es) 2004-04-01
IL139120A0 (en) 2001-11-25
DE59906441D1 (de) 2003-09-04

Similar Documents

Publication Publication Date Title
WO2003059935A3 (en) Methods for purifying protein
RU2004104953A (ru) Способ изолирования тетрамерной формы уриказы и уриказа, полученная данным способом
HUP0102209A2 (hu) Eljárás adenovírus hatékony tisztítására
MY107040A (en) Continuous process and apparatus for the chromatographic separation of a mixture of at least three constituents into three effluents purified by means of two solvents
EP1526174A3 (en) Compositions comprising viruses and methods for concentrating virus preparations
CA2200301A1 (en) Method for fractionation of sucrose-containing solutions
BR0111205A (pt) Separação de uma corrente de produção de hidrocarboneto em seus constituintes de óleo,água e partìcula
WO2003074526A3 (en) Method and system for separation and purification of at least one narcotic alkaloid using reverse phase preparative chromatography
ATE307649T1 (de) Kontinuierliches verfahren zur trennung von stoffen nach molekülgrösse
FR2459479B1 (fr) Procede de separation d'une substance proteinique a partir d'une solution la contenant par filtration d'affinite et application dudit procede aux dosages enzymatiques
JP3408818B2 (ja) 高度に精製されたシクロスポリンaおよび関連シクロスポリン類を得るためのクロマトグラフィー方法
NO20005937D0 (no) Fremgangsmåte for separering og/eller isolering av plasmaproteiner ved annulær kromatografi
SE8302483D0 (sv) Forfarande vid rening av biologiskt aktiva substanser
RU98119067A (ru) Хроматографический способ получения высокочистого циклоспорина a и родственных циклоспоринов
EA199800685A1 (ru) Разделение компонентов плазмы крови с помощью фильтрующих средств на основе целлюлозы
SE9803224D0 (sv) Method for separation of macromolecules
GB0022713D0 (en) Method for fractionating liquid mixtures
Tomlinson et al. Strategy for isolating and sequencing biologically derived MHC class I peptides
EP0199470A3 (en) Method and apparatus for separating complex mixtures of bio-organic materials
WO2002050524A3 (de) Trägerfreies elektrophoreseverfahren und elektrophoresevorrichtung zur durchführung dieses verfahrens
WO2003087756A3 (en) Chemical analysis of samples
MY134912A (en) Method for separating and/or isolating plasma proteins by annularchromatography.
RU98123499A (ru) Способ очистки сырого продукта, содержащего циклоспориновый комплекс, циклоспорин а высокой чистоты и способ промышленного масштаба для очистки циклоспорина а
NZ503589A (en) Order charge separation and order-charge type separation
AU5519596A (en) Method and centrifugal separator for separation of two liqui ds

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application